Home/Filings/4/0001860008-25-000007
4//SEC Filing

Telman Deborah H 4

Accession 0001860008-25-000007

CIK 0000882095other

Filed

Oct 26, 8:00 PM ET

Accepted

Oct 27, 7:43 PM ET

Size

8.4 KB

Accession

0001860008-25-000007

Insider Transaction Report

Form 4
Period: 2025-10-25
Telman Deborah H
EVP, Corporate Affairs & GC
Transactions
  • Tax Payment

    Common Stock

    2025-10-25$120.94/sh241$29,14743,676 total
  • Exercise/Conversion

    Common Stock

    2025-10-25+51543,917 total
  • Exercise/Conversion

    Restricted Stock Unit

    2025-10-2551519,816 total
    Common Stock (515 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
  • [F2]The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.

Issuer

GILEAD SCIENCES, INC.

CIK 0000882095

Entity typeother

Related Parties

1
  • filerCIK 0001860008

Filing Metadata

Form type
4
Filed
Oct 26, 8:00 PM ET
Accepted
Oct 27, 7:43 PM ET
Size
8.4 KB